Author

Elli-Anna Stylianaki

Alexander Fleming Biomedical Sciences Research CenterORCID 0009-0002-9177-6260Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Vassilis AidinisiD· 2 shared Alexios N. MatralisiD· 1 shared Angeliki ChroniiD· 1 shared Antreas AfantitisiD· 1 shared Argyris PolitisiD· 1 shared Aroosha RajaiD· 1 shared Athol Umfrey WellsiD· 1 shared Christiana MagkriotiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Vassilis AidinisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologybioRxivPreprintNov 12, 2025

An aerosolised dual-action Autotaxin inhibitor- PPARγ agonist for the treatment of pulmonary fibrosis

Alexios N. Matralis, Elli-Anna Stylianaki, Eleni M. Ladopoulou…·Vassilis Aidinis

This paper introduces EL244, a dual ATX inhibitor and PPARγ agonist for treating pulmonary fibrosis, showing reduced LPA levels and fibrosis in a bleomycin model.

DOI 10.1101/2025.11.12.687859

mouseexperimental assay

𝕏 PostBluesky

BiochemistryMolecular & Cellular ProteomicsPeer-reviewedApr 6, 2025

ERAP1 activity modulates the immunopeptidome but also affects the proteome, metabolism and stress responses in cancer cells

Martha Nikopaschou, Martina K. Samiotaki, Elli-Anna Stylianaki…·Efstratios Stratikos

This study shows that ERAP1 inhibition alters the immunopeptidome and proteome in cancer cells, affecting metabolism and stress responses, but only a small fraction of proteomic changes impact the immunopeptidome.

12 citationstop 5%

humanproteomics

𝕏 PostBluesky